East Rutherford, NJ – February 8 2016 – Cambrex Corporation (NYSE: CBM, “Cambrex”), an innovative life sciences company that develops and commercializes small molecule active pharmaceutical ingredients (APIs) for the pharmaceutical industry, is pleased to announce that it has been awarded CMO Leadership Awards in the areas of quality, reliability, capabilities, expertise and compatibility.
Steven M. Klosk, President and CEO of Cambrex commented, “I am extremely proud that Cambrex has for the second consecutive year been selected as a winner of the CMO Leadership Awards. Cambrex has a strong customer focus and a commitment to world class quality. Receiving the awards in the five critical categories demonstrates our continued commitment to our customers and recognition by the pharmaceutical industry.”
Now in its fifth year, Life Science Leader’s CMO Leadership Awards 2016 were based on industry research conducted by Industry Standard Research (ISR) to determine the award recipients. More than 80 contract manufacturing organisations were assessed by 26 performance metrics in ISR’s annual Contract Manufacturing Quality Benchmarking Survey. Award recipients were evaluated by the pharmaceutical and biopharmaceutical companies using CMO services.
Customers rated Cambrex as either exceeding expectations or being the top performer within the overall (combined Big and Small Pharma) category for quality, reliability, capabilities, expertise and compatibility.
Cambrex will accept the awards at the CMO Leadership Awards Ceremony and Reception on March 16, 2016 at the W Hotel in New York City.